OPTIMAL. SOLUTIONS While some businesses may offer a packaged approach to energy services, XxXxxxxxx likes to explore the opportunities specific to your facilities, organization, goals, and needs. Whether your challenges stem from financial constraints, building functionality, system operations, or other issues, XxXxxxxxx will offer open and honest recommendations specific to your unique situation. City of Corpus C Mc XXXXXXX.XXX 000 000 0000 XxXxxxxxx in Texas Local experts, national leaders Projects completed by XxXxxxxxx’x Texas team energy, operational, and financial savings as well as capital cost avoidance for our customers. Take a look at the savings results we have achieved together to date: UTILITY SAVINGS $18+ million McKinstry's Texas team creates high-performing facilities. We help public and private customers develop, fund, and implement solutions that make their facilities run better, cost less to operate, last longer, and look and feel more comfortable to occupants. have resulted in significant McKinstry's local presence includes three offices serving the state of Texas. We have more than 100 employees in the region, backed by a national network of more than 1,800 people. Our customers benefit from a strong local team and the collective expertise of our 50+ year-old family of companies. REGIONAL FOCUS • Started ESCO business in 2008 • Locations in Dallas, Houston, and San Antonio OUR SERVICES in our We offer an array of energy and facility capabilities in our Texas region, including: OPERATIONAL SAVINGS $5.8+ million ELECTRICITY Commissioning Construction management Design-build Energy auditing OUR CUSTOMERS Engineering and design High performance general contracting Measurement and verification Project financing support 149+ million kWh We also help our clients apply for and manage a variety of financial incentives. See how we've helped our customers since 2009: XxXxxxxxx has performed more than 90 projects in the region since 2008 to improve energy efficiency and extend the lives of customers' facilities. Many of these customers have elected to engage XxXxxxxxx in multiple phases of work. Our clients come from a variety of markets including the following: K-12 school districts Colleges and universities Cities and counties Data centers Healthcare Biomedical research facilities UTILITY INCENTIVES & GRANT FUNDING
OPTIMAL. ABA privately communicates (ln + n4n) bits and re- quires (n3) invocations to ABA (for single bit) and AVSS protocols (for one field element) to agree on an l bit message. Proof: In Optimal-ABA, Checking Phase and Expansion Phase may be executed for at most 2t times and Output Phase may be executed t times (by Lemma 10). O · · In a single execution of Checking Phase, there are at most 2n′2 instances of AVSS. Moreover, there are two executions of ACS to agree on a set of parties of size t′ + 1 and n′ A-cast of n length response vectors. Since n′ = (n), the total communication complexity during one execution of Checking Phase is 2n2 AVSS + 2n ABA + n4 bits. During the execution of Expansion Phase, the most expensive step in terms of communication complexity is the execution of ACS, which will be executed t′ times (the maximum number of iterations of while loop) in the while loop. Since t′ = O(n), this step requires a communication complexity of n2 · ABA. Moreover, during Expansion Phase each party in K will privately send his l/t bit message to exactly one party in K to which it is mapped. As |K| = O(n), this step requires a communication cost of O(nl/t) bits. A single execution of Output Phase requires O(n′2c + n′3n) bits of private communication. Now O(n′2c + n′3n) = O(l + n′3n) as c = [ A+1 | = [ A+1 | and n′ = O(n), t′ = O(n). td tt' So executing Checking Phase and Expansion phase 2t = Θ(n) times and executing Output Phase t times require a communication complexity of O(ln + n4n) bits plus O(n3) invocations to ABA and AVSS protocols. 2
OPTIMAL. Stem cells are not considered to be a cure for any condition. Treatment with stem cells is considered investigative, although stem cells are present and active in every human being. In fact, we could not survive without our stem cells! Each vial of stem cells is from a single donor (unlike IVIG transfusions, which come from thousands of donors.) Each vial of stem cells is extensively tested for disease, but this is not a guarantee that it is disease-free. Intials Adding a stem cell injection or infusion to your WOW week will take your program to a completely new level with millions of vibrant human stem cells and tissue cells. However, patients with the following conditions should not take stem cell therapy: Allergy or sensitivity to Sulphur or sulpha drugs, unless pre-treated. Allergy or sensitivity to DMSO (dimethyl sulfoxide) Since safety during pregnancy and lactation has not been established, we cannot treat at this time. Active skin infection at the planned injection site Bleeding problems or take strong anticoagulants Intials What are the risks, potential complications and side effects? Mild swelling or bruising or other reaction, such as pain, at the injection sites Infection at injection sites Mild headaches or tightness can occur after injection, usually resolving within a few days Nose and throat irritation, upper respiratory tract/sinus inflammation, flu-like symptoms, “detox” symptoms Nausea Transfer of disease/infection I acknowledge that I have read the entire agreement. I feel I understand its contents, and that I have been informed of the risks, benefits, advantages, disadvantages, and possible complications of each program. All my questions and concerns have been answered; and, by signing below, I hereby give consent to participation. I acknowledge that results are not predictable, and I acknowledge that no guarantees or assurances have or can be made as to the results of participating. I further acknowledge that there have specifically been no guarantees as to the health or cosmetic results of the procedure. I understand that it is my responsibility to know whether I am pregnant and to disclose any medical conditions for which I am currently treated and/or any medications I am taking. By signing below, I confirm that I am not pregnant and that I have fully disclosed my medical history. Date: Date Patient’s Printed Name: Patient Name
OPTIMAL. ACSR/ACP Vista (Business)(1)/ XP (Professional)(2) 500 MHz 1.8 GHz 512 MB 1 GB
OPTIMAL. Less than 100 mg/dL (2.59 mmol/L) Near/above optimal: 100-129 mg/dL (2.59-3.34 mmol/L) Borderline high: 130-159 mg/dL (3.37-4.12 mmol/L) High: 160-189 mg/dL (4.15-4.90 mmol/L) Very high: Greater than 190 mg/dL (4.90 mmol/L) Total Cholesterol levels: Desirable: Less than 200 mg/dL (5.18 mmol/L) Borderline high: 200-239 mg/dL (5.18 to 6.18 mmol/L) High: 240 mg/dL (6.22 mmol/L) or higher HDL Cholesterol levels: Low level, increased risk: Less than 40 mg/dL (1.0 mmol/L) for men and less than 50 mg/dL (1.3 mmol/L) for women Average level, average risk: 40-50 mg/dL (1.0-1.3 mmol/L) for men and between 50-59 mg/dl (1.3-1.5 mmol/L) for women High level, less than average risk: 60 mg/dL (1.55 mmol/L) or higher for both men and women Triglycerides levels: Desirable: Less than 150 mg/dL (1.70 mmol/L) Borderline high: 150-199 mg/dL(1.7-2.2 mmol/L) High: 200-499 mg/dL (2.3-5.6 mmol/L) Very high: Greater than 500 mg/dL (5.6 mmol/L) - Stability level as assessed by XXXX balance scale with a scale range of 30-56
